🔎 Trials Near Me

Akèy › Kansè nan tete › Iowa › Cedar Rapids

Etid klinik pou Kansè nan tete nan Cedar Rapids, IA

17 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Cedar Rapids (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Ap rekriteFaz 1/2
  • University of Iowa Hospitals and Clinics, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06324357

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Local Institution - 0065, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06618287

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Ap rekriteFaz 3
  • University of Iowa, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07174336

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

Ap rekriteFaz 1
  • University of Iowa Hospitals and Clinics, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06756932

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Ap rekriteFaz 3
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
Laj 18 a 60 · Fanm · Mizajou Sep 2, 2026 · NCT05879926

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1
  • University of Iowa, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07029399

Exercise Oncology Clinic Pilot Feasibility Trial

Ap rekrite
  • University of Iowa Health Care, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT07765927

Breast Cancer PSMA PET

Ap rekriteFaz 1 bonè
  • University of Iowa Healthcare, Iowa City · 25 mi lwen
Laj 18 a 90 · Fanm · Mizajou Aug 6, 2026 · NCT06586047

E-Mindfulness Approaches for Living After Breast Cancer

Ap rekriteFaz 3
  • Saint Luke's Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
Laj 18 a 50 · Tout sèks · Mizajou Aug 4, 2026 · NCT06748222

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • University of Iowa, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

Ap rekriteFaz 4
  • Iowa Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT06169371

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Ap rekriteFaz 1
  • University of Iowa Health Care, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT05283330

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • Saint Luke's Hospital, Cedar Rapids
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

Quantitative MRI Assessment of Breast Cancer Therapy Response

Ap rekriteEtid obsèvasyon
  • University of Iowa, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 17, 2026 · NCT05704062

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • Physicians' Clinic of Iowa PC, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Iowa City · 25 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè nan tete nan lòt vil

Lòt etid nan Cedar Rapids

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.